Treating menopausal symptoms with a complex remedy or placebo: a randomized controlled trial

Area of Science:

• Complementary and Alternative Medicine
• Women's Health
• Pharmacology

Background:

• Menopausal symptoms significantly impact women's quality of life.
• There is ongoing research into various treatments, including complex anthroposophic remedies, for symptom management.

Purpose of the Study:

• To evaluate the efficacy and safety of a specific complex anthroposophic remedy versus placebo in treating menopausal symptoms.
• To assess symptom changes using the Menopause Rating Scale II (MRS II).

Main Methods:

• A randomized, placebo-controlled study involving 102 peri- and postmenopausal women.
• Participants received either the complex remedy or placebo in different sequences over 12-week periods.
• The primary endpoint was the change in MRS II scores after 12 weeks.

Main Results:

• No significant difference in symptom reduction was observed between the remedy and placebo groups after 12 weeks (MRS II total score: -1.4 vs. -2.3).
• Treatment for 24 weeks also did not yield clinically relevant improvements.
• Clinically relevant symptom reduction was observed only after three treatment periods in two of the three randomized groups.

Conclusions:

• The complex anthroposophic remedy did not demonstrate clinically significant efficacy in improving menopausal symptoms after 12 or 24 weeks.
• The study suggests that the observed effects might be sequence-dependent or related to the duration of treatment beyond 24 weeks.